NDT Advance Access originally published online on December 23, 2004
Nephrology Dialysis Transplantation 2005 20(3):545-551; doi:10.1093/ndt/gfh617
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thin glomerular basement membrane disease: clinical significance of a morphological diagnosisa collaborative study of the Italian Renal Immunopathology Group
1 U.O. di Nefrologia, Dialisi e Trapianto Renale, Ospedale S. Orsola, Bologna, 2 Dipartimento di Medicina Sperimentale e Patologia, Università La Sapienza, Rome, 3 Genetica Medica, Dipartimento di Biologia Molecolare, Università di Siena, Siena, 4 CMID, Osp. L. Einaudi e U.O. Nefrologia e Immunologia C.I.O.V e Dipartimento Medicina e Oncologia Sperimentale, Università di Torino, Turin, 5 Divisione di Nefrologia e Dialisi, Ospedale Regina Margherita, Turin, 6 Dipartimento di Pediatria, Università di Catania, 7 Divisione di Nefrologia e Dialisi, Viterbo, 8 U.O. di Nefrologia, Dialisi e Trapianto, Ospedale Careggi, Florence 9 Divisione di Nefrologia, Dialisi e Trapianto, Policlinico, Bari, and 10 Nephrology and Dialysis Unit-Umberto I Hospital - V. Conca 71-60020, Ancona, Italy.
Correspondence and offprint requests to: Giovanni M. Frascà, MD, Nephrology, Dialysis and Renal Transplantation Unit, St Orsola University Hospital, V. Massarenti 9, 40137 Bologna, Italy. E-mail: frasca{at}orsola-malpighi.med.unibo.it
Background. Thin glomerular basement membrane disease (TBMD) is a nephropathy defined by diffuse thinning of the glomerular basement membrane (GBM) at electron microscopy examination, without the alterations of Alport's syndrome (ATS). It is known that many patients with TBMD have a type IV collagen disorder and that the disease occasionally may be progressive. This study investigated 51 patients with the morphological diagnosis of TBMD lacking any sign of ATS, with the aim of defining the prevalence of type IV collagen mutations and the course of the disease.
Methods. Patients were investigated as follows: (a) clinical picture and family investigation; (b) renal biopsy findings; (c) immunohistochemical study of renal tissue for collagen IV
-chains; (d) pedigree reconstruction and molecular investigations in genes encoding type IV collagen chains, when DNA samples were available; and (e) follow-up data.
Results. Renal biopsy analysis revealed no light microscopy changes in 27 patients and minimal abnormalities in the remainder. Global glomerular sclerosis was found in seven cases and superimposed mesangial immunoglobulin-A deposits in four. Normal staining of GBM for
(IV) chains was observed in all but one patient, where
5(IV) was absent and molecular investigation revealed a COL4A5 mutation. Five out of 25 cases had a mutation in the COL4A3/COL4A4 genes. Eight out of 38 patients followed up for 12240 months (21%) showed signs of disease progression or hypertension.
Conclusions. This study confirms that a considerable proportion of patients with TBMD have a type IV collagen disorder and that this lesion is not always benign. Thus, families should be investigated carefully whenever possible and patients and affected relatives should be examined periodically for signs of disease progression.
Keywords: Alport's syndrome; benign familial haematuria; COL4A3; COL4A4; mutations; thin basement membrane disease
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Pierides, K. Voskarides, Y. Athanasiou, K. Ioannou, L. Damianou, M. Arsali, M. Zavros, M. Pierides, V. Vargemezis, C. Patsias, et al. Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2721 - 2729. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Marcocci, V. Uliana, M. Bruttini, R. Artuso, M. C. Silengo, M. Zerial, F. Bergesio, A. Amoroso, S. Savoldi, M. Pennesi, et al. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1464 - 1471. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Beirowski, M. Weber, and O. Gross Chronic Renal Failure and Shortened Lifespan in COL4A3+/- Mice: An Animal Model for Thin Basement Membrane Nephropathy J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1986 - 1994. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Longo, E. Scala, F. Mari, R. Caselli, C. Pescucci, M. A. Mencarelli, C. Speciale, M. Giani, E. Bresin, D. A. Caringella, et al. Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families Nephrol. Dial. Transplant., March 1, 2006; 21(3): 665 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Tungekar and T. M. Pickett On the methodology for measuring thickness of glomerular basement membranes Nephrol. Dial. Transplant., October 1, 2005; 20(10): 2287 - 2287. [Full Text] [PDF] |
||||

